Found 4 matching trials
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
PHASE3This is an open-label, multicenter, extension study to evaluate the long-te...
Location
Mount Sinai Medical Center Braman Comprehensive Cancer Center
BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors
PHASE1The primary objective of this study is to assess the safety and tolerabilit...
Location
Icahn School of Medicine At Mount Sinai
A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
PHASE2The main objective of this study was to evaluate the anti-tumor activity of...
Location
Cancer Hospital Chinese Academy of Medical Sciences
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
PHASE2The purpose of this study is to assess the antitumor activity, safety, and ...
Status
Active Not Recruiting
Location
Valkyrie Clinical Trials